Kouji Eguchi’s updated beneficial ownership in Medirom Healthcare Technologies Inc. stands at 2,031,558 Common Shares, or 25.11%, under an activist Schedule 13D. The position includes 186,500 exercisable Options and reflects a 79,945-share transfer for no consideration, giving investors the stated ownership structure and transaction details.

Key Highlights

  • Kouji Eguchi beneficially owns 2,031,558 Common Shares, representing 25.11% of the outstanding Common Shares.
  • COZY LLC beneficially owns 47,543 Common Shares, equal to 0.60%.
  • The amendment reflects a July 18, 2025 grant of 36,500 options and an August 27, 2026 transfer of 79,945 common shares for no consideration.

Medirom Healthcare Technologies Inc. (NASDAQ: MRM) lists Kouji Eguchi as the beneficial owner of 2,031,558 Common Shares, representing 25.11% of the outstanding Common Shares. The ownership is reported under an activist Schedule 13D. The update reflects a stock-option grant dated July 18, 2025, and a transfer of 79,945 Common Shares dated August 27, 2026, for no consideration. Kouji Eguchi also holds one Class A Share of Medirom Healthcare Technologies Inc.

Eguchi’s 25.11% Position

Eguchi’s beneficial ownership consists of 1,797,515 Common Shares held directly, 22,543 American Depositary Shares held through COZY LLC, 186,500 Common Shares issuable upon the exercise of stock options, and 25,000 Common Shares held by COZY LLC. Each American Depositary Share represents one Common Share. The percentage calculation assumes a total of 8,088,450 issued and outstanding Common Shares. COZY LLC separately beneficially owns 47,543 Common Shares, equal to 0.60% of the outstanding Common Shares. The holding comprises 22,543 American Depositary Shares and 25,000 Common Shares. Eguchi owns and controls 100% of COZY LLC and is therefore deemed to have sole voting and dispositive power over its Common Shares.

Stock Options and Share Transfer

Eguchi’s total option position also includes 150,000 options granted on October 30, 2020. Those options had an exercise period beginning October 1, 2021, carry an exercise price of JPY 2,000 per share and have an exercise period ending September 30, 2026. The 36,500 options granted in July 2025 may be exercised only upon Medirom Healthcare Technologies Inc. achieving certain Revenue targets. The option terms identify the total option position as 186,500 Common Shares.

Revenue Targets Govern Options

The related exercise period runs from July 18, 2026, through July 17, 2030. The earlier option grant covers 150,000 Common Shares and has an exercise period ending September 30, 2026.